Your browser doesn't support javascript.
loading
A snapshot of the vast array of diamagnetic CEST MRI contrast agents.
Longo, Dario Livio; Carella, Antonella; Corrado, Alessia; Pirotta, Elisa; Mohanta, Zinia; Singh, Aruna; Stabinska, Julia; Liu, Guanshu; McMahon, Michael T.
Afiliación
  • Longo DL; Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Turin, Italy.
  • Carella A; Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Turin, Italy.
  • Corrado A; Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Turin, Italy.
  • Pirotta E; Institute of Biostructures and Bioimaging (IBB), National Research Council of Italy (CNR), Turin, Italy.
  • Mohanta Z; F.M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Singh A; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Stabinska J; F.M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
  • Liu G; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • McMahon MT; F.M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
NMR Biomed ; 36(6): e4715, 2023 06.
Article en En | MEDLINE | ID: mdl-35187749
Since the inception of CEST MRI in the 1990s, a number of compounds have been identified as suitable for generating contrast, including paramagnetic lanthanide complexes, hyperpolarized atom cages and, most interesting, diamagnetic compounds. In the past two decades, there has been a major emphasis in this field on the identification and application of diamagnetic compounds that have suitable biosafety profiles for usage in medical applications. Even in the past five years there has been a tremendous growth in their numbers, with more and more emphasis being placed on finding those that can be ultimately used for patient studies on clinical 3 T scanners. At this point, a number of endogenous compounds present in tissue have been identified, and also natural and synthetic organic compounds that can be administered to highlight pathology via CEST imaging. Here we will provide a very extensive snapshot of the types of diamagnetic compound that can generate CEST MRI contrast, together with guidance on their utility on typical preclinical and clinical scanners and a review of the applications that might benefit the most from this new technology.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Medios de Contraste Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: NMR Biomed Asunto de la revista: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Medios de Contraste Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: NMR Biomed Asunto de la revista: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido